Health & Biotech
Revealed: Bionic heart to make us live longer
Health Check: Coronary plaque buster Artrya launches $80 million raising
Dr Boreham’s Crucible: Thomas the change engine plans improved track for Mach7
Big Pharma to showcase Clever Culture’s APAS Independence technology
Study shows 81pc success rate for Orthocell Remplir nerve repair product
Health Check: Memphasys inks its first major deal to sort the ‘swimmers’ from the ‘floaters’
MoneyTalks: Morgans’ Scott Power spotlights three ASX healthcare stocks
ASX Health August Winners: Only lucky ones come out on top as CSL sparks 13pc sector sell-off
Aussie start-up Nutromics behind ‘lab on a patch’ that replaces blood tests raises $7.5m
Health Check: Compumedics isn’t dozing on the job after crucial US assent for its single-use home sleep test
Could EZZ’s strong Asian presence make it a takeover target?
Health Check: Argenica hits stroke safety endpoints; efficacy results mixed
HealthInvest returns to Sydney, highlighting emerging ASX healthcare talent
Transformative journey driving Argent BioPharma’s growth and US listing plans
Biocurious: ASX drug developers see silver lining in FDA’s interventionist approach
Health Check: Polynovo shares go crackers after positive US reimbursement changes
Dr Boreham’s Crucible: CSL layer cake fails investor taste test – what’s next on the menu?
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
